Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
905.38
-3.66 (-0.40%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
85
86
Next >
After a 90% Gain, Is It Too Late to Buy Eli Lilly?
February 04, 2024
Its drug tirzepatide showed top efficacy as a weight-loss treatment according to the latest real-world data.
Via
The Motley Fool
7 Mutual Funds That Will Outperform in Any Market
February 03, 2024
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds.
Via
InvestorPlace
SPDR ETF Report For Friday, February 2
February 03, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Friday, February 2.
Via
Talk Markets
Topics
ETFs
3 Pharma Stocks to Sell in February Before They Crash and Burn
February 02, 2024
The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.
Via
InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Market Whales and Their Recent Bets on LLY Options
February 01, 2024
Via
Benzinga
What's Going On With Eli Lilly Stock Today?
February 02, 2024
Eli Lilly reveals Q4 2023 results on Feb 6. Analysts anticipate $2.19 EPS, $8.932 billion in sales. Explore recent developments and FDA inspection.
Via
Benzinga
Exposures
Product Safety
The Road to a Trillion: 3 Stocks Next in Line for the Mega Milestone
February 01, 2024
Becoming a trillion-dollar milestone stock is more than just having a title. Rather, it indicates market dominance in the industry.
Via
InvestorPlace
Eli Lilly To Report Q4 Earnings: What's In The Cards?
February 01, 2024
We expect Eli Lilly & Company to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 6, before the market open.
Via
Talk Markets
Why Eli Lilly Stock Topped the Market Today
January 31, 2024
One of its more recently approved drugs will be launched into a white-hot market.
Via
The Motley Fool
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024
January 31, 2024
Biotech stocks are warming up in January and look to continue upward in 2024 as the economy improves. Here are three to check out.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares
January 31, 2024
Eli Lilly to report strong Q4 earnings thanks to successful diabetes treatments, while rivals like Novo Nordisk and Pfizer are also vying for a share of the weight-loss market.
Via
Benzinga
How Is The Market Feeling About Eli Lilly?
January 29, 2024
Via
Benzinga
Eli Lilly Unusual Options Activity
January 26, 2024
Via
Benzinga
Elliott Wave Technical Analysis: Eli Lilly & Co. - Wednesday, Jan. 31
January 31, 2024
Looking for further upside into wave {v} as we seem to have successfully broken the previous Elliott Wave triangle in wave {iv}.
Via
Talk Markets
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.
Via
Benzinga
Tech Giants' Market Concentration Echoes Dot-Com Bubble Peak, Analysts Warn
January 30, 2024
Explore JPMorgan's analysis drawing parallels between today's US equity market and the dot-com bubble, highlighting the significant concentration of top stocks and sector dominance in the MSCI USA...
Via
Benzinga
Will Novo Nordisk Be a $1 Trillion Company by 2030?
January 30, 2024
Novo Nordisk's market cap has ballooned thanks to the overwhelming success of its Ozempic, Wegovy, and Rybelsus medications.
Via
The Motley Fool
Why Beam Therapeutics Stock Zoomed 17% Higher Today
January 29, 2024
JPMorgan Chase becomes the latest institution in the company's bull pen.
Via
The Motley Fool
Eli Lilly Wants to Expand Access to Weight-Loss Treatments In Germany, In Talks With Government
January 29, 2024
Eli Lilly in talks with German government to lift ban on health system coverage for weight-loss treatments. Explore Mounjaro's recent EU approval and market launches.
Via
Benzinga
Better Buy in 2024: The "Magnificent Seven" or the "Terrific 10"?
January 29, 2024
The financial and healthcare sectors make up a massive amount of the market.
Via
The Motley Fool
Want to Get Richer in 2024? 2 Top Stocks to Buy Now
January 29, 2024
Both of these companies have revenue drivers to keep the growth going.
Via
The Motley Fool
2 Unstoppable Stocks to Buy and Hold For at Least 10 Years
January 29, 2024
It's hard to bet against these companies right now.
Via
The Motley Fool
Forget The Magnificent Seven. Focus On These Fab Five.
January 28, 2024
Investors put a lot of attention on Nvidia and the rest of the Magnificent Seven. But two of these S&P 500 giants aren't fabulous.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
If You Invested $5,000 in Novo Nordisk in 2019, This Is How Much You Would Have Today
January 27, 2024
The answer may surprise you.
Via
The Motley Fool
Could Eli Lilly Be a Trillion-Dollar Company by 2030?
January 27, 2024
Eli Lilly is the world's largest healthcare company by market cap, and the 10th most valuable business in the world.
Via
The Motley Fool
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
January 26, 2024
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains
Via
InvestorPlace
Blue Chip High Fliers And Dogs
January 26, 2024
Within the blue-chip S&P 100 (the largest stocks in the US), there are currently ten stocks that are up at least 40% over the last two years and 20% over the last three years.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Tesla's Market Cap Dips Below Eli Lilly Following Q4 Revenue Miss: Report
January 25, 2024
Via
Benzinga
Eli Lilly's Famed Obesity And Diabetes Drug, Mounjaro, Comes To UK Patients, Wins Regulatory Clearance For Prefilled Injection Pen
January 25, 2024
Eli Lilly's MHRA-approved Mounjaro KwikPen offers effective diabetes and weight management. Learn about the four-dose version's benefits for type 2 diabetes patients.
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
85
86
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.